Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib.
Avalon JC, Fuqua J, Miller T, Deskins S, Wakefield C, King A, Inderbitzin-Brooks S, Bianco C, Veltri L, Fang W, Craig M, Kanate A, Ross K, Malla M, Patel B.
Avalon JC, et al. Among authors: fang w.
Cardiooncology. 2021 Nov 19;7(1):38. doi: 10.1186/s40959-021-00125-8.
Cardiooncology. 2021.
PMID: 34798905
Free PMC article.